Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics

Building Your Care Team and Preparing for Visits

At a Glance

Children with tyrosinemia type 2 need coordinated follow-up through a metabolic clinic. A metabolic doctor, dietitian, eye and skin specialists, and developmental clinicians monitor different needs; families should bring lab, genetic, growth, symptom, and diet records and keep a written sick-day plan.

Because Tyrosinemia Type 2 is exceptionally rare, managing it effectively requires a group of specialists who work together. Building this “care team” ensures that every part of your child’s health—from their vision and skin to their brain development—is monitored by someone with the right expertise.

Your Multidisciplinary Team

A metabolic center will typically coordinate your child’s care. Your team should include the following specialists:

  • Metabolic Geneticist (Metabolic Physician): This is the “captain” of your team. They confirm the diagnosis using genetic and biochemical tests and oversee the entire treatment plan [1][2].
  • Metabolic Dietitian: This role is essential. The dietitian calculates your child’s specific protein allowance and prescribes the medical formula needed for growth [1]. They are your primary resource for daily meal planning and troubleshooting [3].
  • Pediatric Ophthalmologist: Because tyrosine crystals can damage the cornea, a specialized eye doctor will perform regular slit-lamp exams to check for lesions or ulcers [4][5].
  • Pediatric Dermatologist: They manage the painful skin thickening (palmoplantar hyperkeratosis) that can occur on the hands and feet [6][7].
  • Pediatric Neurologist or Developmental Pediatrician: These specialists monitor for developmental milestones and cognitive health, ensuring that any delays are caught and addressed early [8][2].

Depending on your family’s needs, your team might also include a genetic counselor to discuss sibling testing, a social worker for psychological support, and a primary care physician to coordinate routine care.

Preparing for Your First Visit

Your first appointment at a metabolic clinic can be long and detail-oriented. Arriving prepared helps the team make the most accurate assessment.

Records to Bring

Gather the following documents and have them organized in a folder:

  • Newborn Screening Report: Even if it was reported as “normal,” the specific values can be helpful [6].
  • Full Lab Results: Specifically, bring copies of all plasma amino acid tests (showing tyrosine and phenylalanine levels) and succinylacetone results [9][4].
  • Genetic Testing Reports: The complete report for the TAT gene sequencing, including the exact mutations (variants) found [9].
  • Specialist Notes: Any records from eye exams, skin biopsies, or previous hospital visits.
  • Growth Charts: A record of your child’s height and weight over time.

Symptom and Diet History

Be ready to discuss:

  • The Timeline: When did eye redness, light sensitivity, or skin patches first appear [6]?
  • Prior Treatments: List any eye drops (especially antivirals like those for HSV) or skin creams you have used and whether they helped [5][7].
  • Current Diet: If possible, keep a three-day log of everything your child eats and drinks before the visit. This helps the dietitian understand your starting point [7][8].

Vetting Your Care Team and Emergency Planning

Not all metabolic clinics have extensive experience with Tyrosinemia Type 2, as it is much rarer than Type 1. When meeting a new team, it is important to confirm they understand the specific needs of Type 2.

Ask if they have a clear distinction in their protocol between Type 1 and Type 2. For example, a clinic should be able to confirm that they do not use the medication nitisinone for Type 2, as it is not the standard treatment and can raise tyrosine levels [10][11].

A well-coordinated team will have a written plan for monitoring, dietary adjustments, and a clear way for you to contact them. You should ask the clinic to provide a printable medical-alert card stating the TAT diagnosis, succinylacetone status, the warning against nitisinone, and your specific emergency “sick day” plan.

Common questions in this guide

Which specialists should care for a child with tyrosinemia type 2?
A metabolic geneticist or metabolic physician usually coordinates diagnosis and the overall plan. A metabolic dietitian manages protein allowance and medical formula, while pediatric eye, skin, and developmental specialists monitor the main areas affected. A genetic counselor, social worker, and primary care clinician may also help.
What records should I bring to the first tyrosinemia type 2 clinic visit?
Bring the newborn screening report, plasma amino acid results, succinylacetone result, complete TAT gene report, specialist notes, and growth charts. These records help the team understand what has been tested and track your child’s health over time.
Why are regular eye and skin exams important in tyrosinemia type 2?
Tyrosine crystals can injure the cornea, and a pediatric ophthalmologist can use slit-lamp exams to look for lesions or ulcers. A pediatric dermatologist can assess painful thickened skin on the palms and soles, called palmoplantar hyperkeratosis.
How should I prepare my child’s symptom and diet history?
Write down when eye redness, light sensitivity, or skin patches first appeared, and list eye drops or creams previously used and whether they helped. A three-day record of all food and drinks can help the dietitian plan the protein allowance and medical formula.
Is nitisinone used to treat tyrosinemia type 2?
Nitisinone is not the standard treatment for tyrosinemia type 2 and may raise tyrosine levels. Ask the metabolic clinic to confirm the diagnosis-specific medication plan, and do not start or stop a medicine without the treating team.
What should a tyrosinemia type 2 sick-day and emergency plan include?
The clinic should provide written instructions for diet changes, what to do if your child cannot drink medical formula, and how to contact the team. A medical-alert card can list the TAT diagnosis, succinylacetone status, warning against nitisinone, and your child’s emergency plan.

Get notified when new evidence is published on Tyrosinemia type 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    [Screening for hereditary tyrosinemia and genotype analysis in newborns].

    Tong F, Yang R, Liu C, et al.

    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2019; (48(4)):459-464 doi:10.3785/j.issn.1008-9292.2019.08.18.

    PMID: 31901053
  2. 2

    Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation.

    Peña-Quintana L, Scherer G, Curbelo-Estévez ML, et al.

    Clinical genetics 2017; (92(3)):306-317 doi:10.1111/cge.13003.

    PMID: 28255985
  3. 3

    Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.

    Chinsky JM, Singh R, Ficicioglu C, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(12)) doi:10.1038/gim.2017.101.

    PMID: 28771246
  4. 4

    An Infant with Bilateral Keratitis: From Infectious to Genetic Diagnosis.

    Thibault LP, Mitchell GA, Parisien B, et al.

    The American journal of case reports 2022; (23()):e937967 doi:10.12659/AJCR.937967.

    PMID: 36447403
  5. 5

    Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome.

    Soares DC, Stroparo MN, Lian YC, et al.

    Journal of inherited metabolic disease 2017; (40(3)):461-462 doi:10.1007/s10545-016-9996-z.

    PMID: 27832414
  6. 6

    A child with dendritiform eye lesions and developmental delay.

    Gliagias V, Denisova K, Kang JJ

    American journal of ophthalmology case reports 2022; (28()):101701 doi:10.1016/j.ajoc.2022.101701.

    PMID: 36118278
  7. 7

    Bilateral dendriform ulcer leading to an early diagnosis of tyrosinemia type 2.

    Martin GC, de Lonlay P, Chapron T, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2020; (24(2)):120-122 doi:10.1016/j.jaapos.2019.12.007.

    PMID: 32018000
  8. 8

    Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation.

    Gokay S, Kendirci M, Ustkoyuncu PS, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2016; (58(10)):1069-1072 doi:10.1111/ped.13062.

    PMID: 27285949
  9. 9

    Case Report: Type II tyrosinemia caused by mutations at the c.843_844 inv p.(Trp282Gly) variant locus.

    Tong F, Peng M, Meng L, et al.

    Frontiers in genetics 2026; (17()):1753440 doi:10.3389/fgene.2026.1753440.

    PMID: 41890226
  10. 10

    Predicting tyrosinaemia: a mathematical model of 4-hydroxyphenylpyruvate dioxygenase inhibition by nitisinone in rats.

    Ward JP, Dunster JL, Derks G, et al.

    Mathematical medicine and biology : a journal of the IMA 2017; (34(3)):335-390 doi:10.1093/imammb/dqw006.

    PMID: 27305933
  11. 11

    Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in Tyrosinemia.

    Honar N, Shakibazad N, Serati Shirazi Z, et al.

    Iranian journal of child neurology 2017; (11(4)):66-70.

    PMID: 29201126

This page is for informational purposes only and does not replace medical advice. Your child’s metabolic team should confirm the right specialists, tests, diet plan, medicines, and emergency instructions for your family.